IDEXX sets November 2 results date and IDEXX Laboratories stock costs EUR 462.25
Published on 10/05/2026 at 10:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IDEXX Laboratories stock was trading at EUR 462.25 at Lang & Schwarz on October 5, 2026 at 10:38 a.m. CEST, with a daily change of plus 0.35 percent versus the prior close of EUR 460.65. IDEXX Laboratories scheduled its third-quarter 2026 results for November 2, 2026, per the company's October 1 release published by IDEXX Laboratories.
November results set the next test
The scheduled release will be the next major checkpoint after IDEXX Laboratories reported second-quarter results for the period ended June 30, 2026. According to MarketBeat on October 5, 2026, revenue reached USD 1.22 billion, up 9.70 percent from the prior year, while earnings per share came to USD 4.27 versus a USD 3.94 consensus estimate.
The comparison gives the November report a clear benchmark. IDEXX also set fiscal 2026 earnings-per-share guidance at USD 14.69-14.94, while analysts cited by MarketBeat forecast USD 14.81 for the full year.
Analyst targets remain above the market
MarketBeat says six of ten covering analysts rate IDEXX Laboratories a Buy and four rate it a Hold. The average one-year target is USD 747.00, while the same source reports a fiscal 2026 earnings-per-share consensus of USD 14.81.
The target and guidance figures frame the stock's valuation debate in different currencies from the Lang & Schwarz quote. The operating picture is tied to veterinary diagnostics, software, laboratory services and water-testing products, giving the November report several business lines to assess.
EUR 462.25 ahead of the results date
At Lang & Schwarz, IDEXX Laboratories stock was trading at EUR 462.25 on October 5, 2026 at 10:38 a.m. CEST, plus 0.35 percent versus the prior close of EUR 460.65 on October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of IDEXX Laboratories stock.
IDEXX Laboratories stock facts
- Company: IDEXX Laboratories, Inc.
- ISIN: US45168D1046
- Ticker: IDXX
- Primary exchange: NASDAQ
- Price Lang & Schwarz (as of October 5, 2026, 10:38 a.m. CEST): EUR 462.25
- Change versus prior close: plus 0.35 percent
- Prior close Lang & Schwarz (October 2, 2026): EUR 460.65
- Market capitalization: USD 40.8 billion (as of October 5, 2026)
- 52-week range: USD 500.61-769.98 (as of October 5, 2026)
- Sector / Industry: Healthcare / Healthcare Equipment and Supplies
- Next earnings date: November 2, 2026
